HEADER TRANSPORT PROTEIN 26-JUL-05 2BXH TITLE HUMAN SERUM ALBUMIN COMPLEXED WITH INDOXYL SULFATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERUM ALBUMIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HUMAN SERUM ALBUMIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: PLASMA; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS TRANSPORT PROTEIN, ALBUMIN, CARRIER PROTEIN, LIPID-BINDING, METAL- KEYWDS 2 BINDING, DRUG-BINDING, INDOXYL SULFATE EXPDTA X-RAY DIFFRACTION AUTHOR J.GHUMAN,P.A.ZUNSZAIN,I.PETITPAS,A.A.BHATTACHARYA,S.CURRY REVDAT 6 06-NOV-24 2BXH 1 REMARK REVDAT 5 13-DEC-23 2BXH 1 REMARK REVDAT 4 24-JUL-19 2BXH 1 REMARK REVDAT 3 24-FEB-09 2BXH 1 VERSN REVDAT 2 20-DEC-06 2BXH 1 JRNL REVDAT 1 22-SEP-05 2BXH 0 JRNL AUTH J.GHUMAN,P.A.ZUNSZAIN,I.PETITPAS,A.A.BHATTACHARYA,M.OTAGIRI, JRNL AUTH 2 S.CURRY JRNL TITL STRUCTURAL BASIS OF THE DRUG-BINDING SPECIFICITY OF HUMAN JRNL TITL 2 SERUM ALBUMIN. JRNL REF J.MOL.BIOL. V. 353 38 2005 JRNL REFN ISSN 0022-2836 JRNL PMID 16169013 JRNL DOI 10.1016/J.JMB.2005.07.075 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : MLF REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.03 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 984960.690 REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 58737 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.266 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2973 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.39 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 9325 REMARK 3 BIN R VALUE (WORKING SET) : 0.3750 REMARK 3 BIN FREE R VALUE : 0.3830 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 451 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 8486 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 54 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.10000 REMARK 3 B22 (A**2) : 1.01000 REMARK 3 B33 (A**2) : -13.11000 REMARK 3 B12 (A**2) : -10.75000 REMARK 3 B13 (A**2) : 6.51000 REMARK 3 B23 (A**2) : -4.96000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35 REMARK 3 ESD FROM SIGMAA (A) : 0.46 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.41 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.52 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 19.10 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : GROUP REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.27 REMARK 3 BSOL : 49.67 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : IDS.PAR REMARK 3 PARAMETER FILE 3 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : IDS.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2BXH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-05. REMARK 100 THE DEPOSITION ID IS D_1290025061. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 298.0 REMARK 200 PH : 7.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : X13 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8019 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58748 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 36.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.7 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.04000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.1 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.39000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1E78 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.43 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.00 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 1 REMARK 465 ALA A 2 REMARK 465 HIS A 3 REMARK 465 LYS A 4 REMARK 465 ASP A 562 REMARK 465 ASP A 563 REMARK 465 LYS A 564 REMARK 465 GLU A 565 REMARK 465 THR A 566 REMARK 465 CYS A 567 REMARK 465 PHE A 568 REMARK 465 ALA A 569 REMARK 465 GLU A 570 REMARK 465 GLU A 571 REMARK 465 GLY A 572 REMARK 465 LYS A 573 REMARK 465 LYS A 574 REMARK 465 LEU A 575 REMARK 465 VAL A 576 REMARK 465 ALA A 577 REMARK 465 ALA A 578 REMARK 465 SER A 579 REMARK 465 GLN A 580 REMARK 465 ALA A 581 REMARK 465 ALA A 582 REMARK 465 LEU A 583 REMARK 465 GLY A 584 REMARK 465 LEU A 585 REMARK 465 ASP B 1 REMARK 465 ALA B 2 REMARK 465 HIS B 3 REMARK 465 LYS B 4 REMARK 465 ASP B 562 REMARK 465 ASP B 563 REMARK 465 LYS B 564 REMARK 465 GLU B 565 REMARK 465 THR B 566 REMARK 465 CYS B 567 REMARK 465 PHE B 568 REMARK 465 ALA B 569 REMARK 465 GLU B 570 REMARK 465 GLU B 571 REMARK 465 GLY B 572 REMARK 465 LYS B 573 REMARK 465 LYS B 574 REMARK 465 LEU B 575 REMARK 465 VAL B 576 REMARK 465 ALA B 577 REMARK 465 ALA B 578 REMARK 465 SER B 579 REMARK 465 GLN B 580 REMARK 465 ALA B 581 REMARK 465 ALA B 582 REMARK 465 LEU B 583 REMARK 465 GLY B 584 REMARK 465 LEU B 585 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 12 CG CD CE NZ REMARK 470 GLU A 17 CG CD OE1 OE2 REMARK 470 LEU A 31 CG CD1 CD2 REMARK 470 GLN A 33 CD OE1 NE2 REMARK 470 LYS A 41 CE NZ REMARK 470 VAL A 54 CG1 CG2 REMARK 470 ASP A 56 CG OD1 OD2 REMARK 470 LYS A 73 CG CD CE NZ REMARK 470 THR A 76 OG1 CG2 REMARK 470 THR A 79 OG1 CG2 REMARK 470 GLU A 82 CG CD OE1 OE2 REMARK 470 GLN A 94 CG CD OE1 NE2 REMARK 470 GLU A 97 CG CD OE1 OE2 REMARK 470 ARG A 98 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 115 CG CD1 CD2 REMARK 470 GLU A 119 CG CD OE1 OE2 REMARK 470 LYS A 136 CE NZ REMARK 470 LYS A 159 CD CE NZ REMARK 470 LYS A 174 CE NZ REMARK 470 GLU A 184 CD OE1 OE2 REMARK 470 LYS A 190 CD CE NZ REMARK 470 LYS A 195 CE NZ REMARK 470 LYS A 205 CD CE NZ REMARK 470 ARG A 209 NE CZ NH1 NH2 REMARK 470 LYS A 240 CD CE NZ REMARK 470 LYS A 276 CD CE NZ REMARK 470 GLU A 277 CG CD OE1 OE2 REMARK 470 GLU A 280 CG CD OE1 OE2 REMARK 470 ASP A 301 OD1 OD2 REMARK 470 LYS A 313 CG CD CE NZ REMARK 470 LYS A 317 CG CD CE NZ REMARK 470 GLU A 321 CG CD OE1 OE2 REMARK 470 LYS A 359 CD CE NZ REMARK 470 ASP A 365 CG OD1 OD2 REMARK 470 GLU A 368 CD OE1 OE2 REMARK 470 GLU A 376 CD OE1 OE2 REMARK 470 LYS A 378 CG CD CE NZ REMARK 470 LYS A 389 CD CE NZ REMARK 470 GLN A 390 CD OE1 NE2 REMARK 470 GLN A 397 CD OE1 NE2 REMARK 470 LYS A 402 CE NZ REMARK 470 LYS A 436 CD CE NZ REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 HIS A 510 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 519 CG CD CE NZ REMARK 470 LYS A 524 CG CD CE NZ REMARK 470 LYS A 536 CG CD CE NZ REMARK 470 LYS A 541 CG CD CE NZ REMARK 470 GLU A 542 CD OE1 OE2 REMARK 470 LYS A 545 CG CD CE NZ REMARK 470 ASP A 550 CG OD1 OD2 REMARK 470 PHE A 551 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE A 554 CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 560 CG CD CE NZ REMARK 470 LYS B 12 CG CD CE NZ REMARK 470 LEU B 31 CG CD1 CD2 REMARK 470 GLN B 33 CD OE1 NE2 REMARK 470 LYS B 41 CG CD CE NZ REMARK 470 ASP B 56 CG OD1 OD2 REMARK 470 GLU B 60 CG CD OE1 OE2 REMARK 470 GLU B 82 CG CD OE1 OE2 REMARK 470 THR B 83 OG1 CG2 REMARK 470 GLU B 86 CG CD OE1 OE2 REMARK 470 LYS B 93 CG CD CE NZ REMARK 470 GLN B 94 CG CD OE1 NE2 REMARK 470 GLU B 97 CG CD OE1 OE2 REMARK 470 ARG B 98 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 104 CD OE1 NE2 REMARK 470 ARG B 114 CG CD NE CZ NH1 NH2 REMARK 470 LEU B 115 CG CD1 CD2 REMARK 470 HIS B 128 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 137 CD CE NZ REMARK 470 LYS B 159 CD CE NZ REMARK 470 LYS B 162 CG CD CE NZ REMARK 470 GLN B 170 CD OE1 NE2 REMARK 470 LYS B 174 CE NZ REMARK 470 LYS B 181 CG CD CE NZ REMARK 470 LYS B 190 CD CE NZ REMARK 470 LYS B 205 CD CE NZ REMARK 470 ARG B 209 CD NE CZ NH1 NH2 REMARK 470 LYS B 225 CD CE NZ REMARK 470 LYS B 240 CD CE NZ REMARK 470 LYS B 262 CG CD CE NZ REMARK 470 LYS B 276 CG CD CE NZ REMARK 470 GLU B 277 CG CD OE1 OE2 REMARK 470 LYS B 281 CE NZ REMARK 470 GLU B 285 CD OE1 OE2 REMARK 470 LYS B 286 CG CD CE NZ REMARK 470 GLU B 292 CG CD OE1 OE2 REMARK 470 LYS B 313 CG CD CE NZ REMARK 470 LYS B 317 CG CD CE NZ REMARK 470 GLU B 321 CG CD OE1 OE2 REMARK 470 LYS B 359 CD CE NZ REMARK 470 ASP B 365 CG OD1 OD2 REMARK 470 LYS B 378 CG CD CE NZ REMARK 470 LYS B 389 CD CE NZ REMARK 470 GLU B 393 CG CD OE1 OE2 REMARK 470 LYS B 402 CD CE NZ REMARK 470 LYS B 436 CD CE NZ REMARK 470 LYS B 444 CD CE NZ REMARK 470 LYS B 466 CG CD CE NZ REMARK 470 GLU B 505 CG CD OE1 OE2 REMARK 470 HIS B 510 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 519 CG CD CE NZ REMARK 470 LYS B 524 CG CD CE NZ REMARK 470 LYS B 536 CG CD CE NZ REMARK 470 LYS B 538 CD CE NZ REMARK 470 LYS B 541 CG CD CE NZ REMARK 470 GLU B 542 CD OE1 OE2 REMARK 470 LYS B 545 CG CD CE NZ REMARK 470 ASP B 550 CG OD1 OD2 REMARK 470 PHE B 551 CG CD1 CD2 CE1 CE2 CZ REMARK 470 PHE B 554 CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 557 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE1 GLU A 495 NH2 ARG B 472 1454 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 447 C - N - CA ANGL. DEV. = -9.1 DEGREES REMARK 500 ARG B 472 NE - CZ - NH2 ANGL. DEV. = -4.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 55 -77.25 -92.07 REMARK 500 GLU A 57 30.41 -60.32 REMARK 500 SER A 58 29.45 -160.39 REMARK 500 ALA A 59 -132.32 -62.25 REMARK 500 GLU A 60 -72.03 -65.49 REMARK 500 ASP A 63 56.48 -95.06 REMARK 500 VAL A 77 -28.36 -150.96 REMARK 500 LEU A 80 91.85 -59.70 REMARK 500 THR A 83 -67.22 -91.08 REMARK 500 TYR A 84 71.60 -115.77 REMARK 500 ASN A 111 95.77 -67.79 REMARK 500 LEU A 115 105.84 -55.03 REMARK 500 PRO A 118 -177.53 -50.60 REMARK 500 PRO A 147 -1.58 -59.31 REMARK 500 TYR A 150 96.73 -60.86 REMARK 500 ALA A 172 -80.61 -57.65 REMARK 500 GLU A 280 46.42 -97.97 REMARK 500 ALA A 307 -70.50 -45.77 REMARK 500 ALA A 322 84.81 -163.73 REMARK 500 PRO A 366 -71.85 -39.75 REMARK 500 HIS A 440 164.62 -47.79 REMARK 500 GLU A 492 -94.00 -116.43 REMARK 500 GLU A 501 -156.90 -89.61 REMARK 500 ASN A 503 95.58 -175.47 REMARK 500 HIS A 510 118.68 -29.78 REMARK 500 ALA A 511 -23.61 -39.51 REMARK 500 ASP A 512 51.92 -63.35 REMARK 500 ALA A 539 171.02 -50.32 REMARK 500 ALA B 55 -86.44 -89.64 REMARK 500 GLU B 57 20.80 -62.54 REMARK 500 ALA B 59 -125.60 -78.66 REMARK 500 ASN B 61 20.25 -151.81 REMARK 500 VAL B 77 -28.87 -147.95 REMARK 500 LEU B 80 80.66 -66.29 REMARK 500 GLN B 94 -166.80 -114.14 REMARK 500 ARG B 114 129.39 -39.74 REMARK 500 PRO B 118 -172.83 -60.02 REMARK 500 ASP B 129 -75.16 -48.16 REMARK 500 ALA B 163 -2.95 -54.51 REMARK 500 CYS B 169 4.62 -63.83 REMARK 500 ALA B 172 -82.38 -29.08 REMARK 500 PHE B 223 66.68 -117.48 REMARK 500 ALA B 226 151.00 -45.63 REMARK 500 ASN B 267 20.64 -70.00 REMARK 500 SER B 270 41.22 -104.71 REMARK 500 ILE B 271 -65.86 -146.47 REMARK 500 LYS B 276 -72.34 -53.07 REMARK 500 GLU B 280 35.07 -93.31 REMARK 500 ALA B 300 -76.91 -43.34 REMARK 500 SER B 312 168.49 -41.73 REMARK 500 REMARK 500 THIS ENTRY HAS 64 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLU B 95 -10.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOS A1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOS A1002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOS B1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOS B1002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1AO6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1BJ5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1BKE RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN IN A COMPLEX WITH MYRISTIC ACID AND TRI- REMARK 900 IODOBENZOIC ACID REMARK 900 RELATED ID: 1BM0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E78 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1E7A RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH THE GENERAL REMARK 900 ANESTHETIC PROPOFOL REMARK 900 RELATED ID: 1E7B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN COMPLEXED WITH HALOTHANE REMARK 900 RELATED ID: 1E7C RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE GENERAL REMARK 900 ANESTHETIC HALOTHANE REMARK 900 RELATED ID: 1E7E RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DECANOIC ACID REMARK 900 RELATED ID: 1E7F RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DODECANOIC ACID REMARK 900 RELATED ID: 1E7G RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID REMARK 900 RELATED ID: 1E7H RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH HEXADECANOIC ACID REMARK 900 RELATED ID: 1E7I RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH OCTADECANOIC ACID REMARK 900 RELATED ID: 1GNI RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-9- OCTADECENOIC ACID (OLEIC REMARK 900 ACID) REMARK 900 RELATED ID: 1GNJ RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH CIS-5,8 ,11,14-EICOSATETRAENOIC REMARK 900 ACID (ARACHIDONIC ACID) REMARK 900 RELATED ID: 1H9Z RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE R-(+) REMARK 900 ENANTIOMER OF WARFARIN REMARK 900 RELATED ID: 1HA2 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTIC ACID AND THE S-(-) REMARK 900 ENANTIOMER OF WARFARIN REMARK 900 RELATED ID: 1HK1 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- REMARK 900 THYRONINE) REMARK 900 RELATED ID: 1HK2 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5' REMARK 900 -TETRAIODO-L- THYRONINE) REMARK 900 RELATED ID: 1HK3 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5' REMARK 900 -TETRAIODO-L- THYRONINE) REMARK 900 RELATED ID: 1HK4 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH THYROXINE (3,3',5,5'-TETRAIODO-L- REMARK 900 THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) REMARK 900 RELATED ID: 1HK5 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN MUTANT R218H COMPLEXED WITH THYROXINE (3,3',5,5' REMARK 900 -TETRAIODO-L- THYRONINE) AND MYRISTIC ACID (TETRADECANOIC ACID) REMARK 900 RELATED ID: 1N5U RELATED DB: PDB REMARK 900 X-RAY STUDY OF HUMAN SERUM ALBUMIN COMPLEXED WITH HEME REMARK 900 RELATED ID: 1O9X RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH TETRADECANOIC ACID (MYRISTIC REMARK 900 ACID) AND HEMIN REMARK 900 RELATED ID: 1TF0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GA MODULE COMPLEXED WITH HUMANSERUM ALBUMIN REMARK 900 RELATED ID: 1UOR RELATED DB: PDB REMARK 900 X-RAY STUDY OF RECOMBINANT HUMAN SERUM ALBUMIN. PHASES DETERMINED REMARK 900 BY MOLECULAR REPLACEMENT METHOD, USING LOW RESOLUTION STRUCTURE REMARK 900 MODEL OF TETRAGONAL FORM OF HUMAN SERUM ALBUMIN REMARK 900 RELATED ID: 1YSX RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF DOMAIN 3 FROM HUMAN SERUM ALBUMINCOMPLEXED TO REMARK 900 AN ANTI-APOPTOTIC LIGAND DIRECTED AGAINST BCL-XL AND BCL-2 REMARK 900 RELATED ID: 2BX8 RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH AZAPROPAZONE REMARK 900 RELATED ID: 2BXA RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH 3-CARBOXY -4-METHYL-5-PROPYL-2- REMARK 900 FURANPROPANOIC ACID ( CMPF) REMARK 900 RELATED ID: 2BXB RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH OXYPHENBUTAZONE REMARK 900 RELATED ID: 2BXC RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH PHENYLBUTAZONE REMARK 900 RELATED ID: 2BXD RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH WARFARIN REMARK 900 RELATED ID: 2BXE RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DIFLUNISAL REMARK 900 RELATED ID: 2BXF RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH DIAZEPAM REMARK 900 RELATED ID: 2BXG RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH IBUPROFEN REMARK 900 RELATED ID: 2BXI RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND AZAPROPAZONE REMARK 900 RELATED ID: 2BXK RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE , AZAPROPAZONE AND REMARK 900 INDOMETHACIN REMARK 900 RELATED ID: 2BXL RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND 3,5- REMARK 900 DIIODOSALICYLIC ACID REMARK 900 RELATED ID: 2BXM RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND INDOMETHACIN REMARK 900 RELATED ID: 2BXN RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND IODIPAMIDE REMARK 900 RELATED ID: 2BXO RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND OXYPHENBUTAZONE REMARK 900 RELATED ID: 2BXP RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE AND PHENYLBUTAZONE REMARK 900 RELATED ID: 2BXQ RELATED DB: PDB REMARK 900 HUMAN SERUM ALBUMIN COMPLEXED WITH MYRISTATE , PHENYLBUTAZONE AND REMARK 900 INDOMETHACIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 SEQUENCE IS FOR PRE-CURSOR. MATURE POLYPEPTIDE WAS REMARK 999 CRYSTALLISED (WHICH LACKS SIGNAL AND PROPEPTIDES - REMARK 999 RESIDUES 1-24) DBREF 2BXH A 1 585 UNP P02768 ALBU_HUMAN 25 609 DBREF 2BXH B 1 585 UNP P02768 ALBU_HUMAN 25 609 SEQRES 1 A 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 A 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 A 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 A 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 A 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 A 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 A 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 A 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 A 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 A 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 A 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 A 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 A 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 A 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 A 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 A 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 A 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 A 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 A 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 A 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 A 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 A 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 A 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 A 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 A 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 A 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 A 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 A 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 A 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 A 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 A 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 A 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 A 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 A 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 A 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 A 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 A 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 A 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 A 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 A 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 A 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 A 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 A 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 A 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 A 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU SEQRES 1 B 585 ASP ALA HIS LYS SER GLU VAL ALA HIS ARG PHE LYS ASP SEQRES 2 B 585 LEU GLY GLU GLU ASN PHE LYS ALA LEU VAL LEU ILE ALA SEQRES 3 B 585 PHE ALA GLN TYR LEU GLN GLN CYS PRO PHE GLU ASP HIS SEQRES 4 B 585 VAL LYS LEU VAL ASN GLU VAL THR GLU PHE ALA LYS THR SEQRES 5 B 585 CYS VAL ALA ASP GLU SER ALA GLU ASN CYS ASP LYS SER SEQRES 6 B 585 LEU HIS THR LEU PHE GLY ASP LYS LEU CYS THR VAL ALA SEQRES 7 B 585 THR LEU ARG GLU THR TYR GLY GLU MET ALA ASP CYS CYS SEQRES 8 B 585 ALA LYS GLN GLU PRO GLU ARG ASN GLU CYS PHE LEU GLN SEQRES 9 B 585 HIS LYS ASP ASP ASN PRO ASN LEU PRO ARG LEU VAL ARG SEQRES 10 B 585 PRO GLU VAL ASP VAL MET CYS THR ALA PHE HIS ASP ASN SEQRES 11 B 585 GLU GLU THR PHE LEU LYS LYS TYR LEU TYR GLU ILE ALA SEQRES 12 B 585 ARG ARG HIS PRO TYR PHE TYR ALA PRO GLU LEU LEU PHE SEQRES 13 B 585 PHE ALA LYS ARG TYR LYS ALA ALA PHE THR GLU CYS CYS SEQRES 14 B 585 GLN ALA ALA ASP LYS ALA ALA CYS LEU LEU PRO LYS LEU SEQRES 15 B 585 ASP GLU LEU ARG ASP GLU GLY LYS ALA SER SER ALA LYS SEQRES 16 B 585 GLN ARG LEU LYS CYS ALA SER LEU GLN LYS PHE GLY GLU SEQRES 17 B 585 ARG ALA PHE LYS ALA TRP ALA VAL ALA ARG LEU SER GLN SEQRES 18 B 585 ARG PHE PRO LYS ALA GLU PHE ALA GLU VAL SER LYS LEU SEQRES 19 B 585 VAL THR ASP LEU THR LYS VAL HIS THR GLU CYS CYS HIS SEQRES 20 B 585 GLY ASP LEU LEU GLU CYS ALA ASP ASP ARG ALA ASP LEU SEQRES 21 B 585 ALA LYS TYR ILE CYS GLU ASN GLN ASP SER ILE SER SER SEQRES 22 B 585 LYS LEU LYS GLU CYS CYS GLU LYS PRO LEU LEU GLU LYS SEQRES 23 B 585 SER HIS CYS ILE ALA GLU VAL GLU ASN ASP GLU MET PRO SEQRES 24 B 585 ALA ASP LEU PRO SER LEU ALA ALA ASP PHE VAL GLU SER SEQRES 25 B 585 LYS ASP VAL CYS LYS ASN TYR ALA GLU ALA LYS ASP VAL SEQRES 26 B 585 PHE LEU GLY MET PHE LEU TYR GLU TYR ALA ARG ARG HIS SEQRES 27 B 585 PRO ASP TYR SER VAL VAL LEU LEU LEU ARG LEU ALA LYS SEQRES 28 B 585 THR TYR GLU THR THR LEU GLU LYS CYS CYS ALA ALA ALA SEQRES 29 B 585 ASP PRO HIS GLU CYS TYR ALA LYS VAL PHE ASP GLU PHE SEQRES 30 B 585 LYS PRO LEU VAL GLU GLU PRO GLN ASN LEU ILE LYS GLN SEQRES 31 B 585 ASN CYS GLU LEU PHE GLU GLN LEU GLY GLU TYR LYS PHE SEQRES 32 B 585 GLN ASN ALA LEU LEU VAL ARG TYR THR LYS LYS VAL PRO SEQRES 33 B 585 GLN VAL SER THR PRO THR LEU VAL GLU VAL SER ARG ASN SEQRES 34 B 585 LEU GLY LYS VAL GLY SER LYS CYS CYS LYS HIS PRO GLU SEQRES 35 B 585 ALA LYS ARG MET PRO CYS ALA GLU ASP TYR LEU SER VAL SEQRES 36 B 585 VAL LEU ASN GLN LEU CYS VAL LEU HIS GLU LYS THR PRO SEQRES 37 B 585 VAL SER ASP ARG VAL THR LYS CYS CYS THR GLU SER LEU SEQRES 38 B 585 VAL ASN ARG ARG PRO CYS PHE SER ALA LEU GLU VAL ASP SEQRES 39 B 585 GLU THR TYR VAL PRO LYS GLU PHE ASN ALA GLU THR PHE SEQRES 40 B 585 THR PHE HIS ALA ASP ILE CYS THR LEU SER GLU LYS GLU SEQRES 41 B 585 ARG GLN ILE LYS LYS GLN THR ALA LEU VAL GLU LEU VAL SEQRES 42 B 585 LYS HIS LYS PRO LYS ALA THR LYS GLU GLN LEU LYS ALA SEQRES 43 B 585 VAL MET ASP ASP PHE ALA ALA PHE VAL GLU LYS CYS CYS SEQRES 44 B 585 LYS ALA ASP ASP LYS GLU THR CYS PHE ALA GLU GLU GLY SEQRES 45 B 585 LYS LYS LEU VAL ALA ALA SER GLN ALA ALA LEU GLY LEU HET IOS A1001 14 HET IOS A1002 28 HET IOS B1001 14 HET IOS B1002 28 HETNAM IOS 3-SULFOOXY-1H-INDOLE FORMUL 3 IOS 4(C8 H7 N O4 S) FORMUL 7 HOH *54(H2 O) HELIX 1 1 SER A 5 LEU A 31 1 27 HELIX 2 2 PRO A 35 ASP A 56 1 22 HELIX 3 3 SER A 65 LEU A 74 1 10 HELIX 4 4 CYS A 75 VAL A 77 5 3 HELIX 5 5 TYR A 84 ALA A 92 1 9 HELIX 6 6 PRO A 96 HIS A 105 1 10 HELIX 7 7 GLU A 119 ASN A 130 1 12 HELIX 8 8 ASN A 130 HIS A 146 1 17 HELIX 9 9 TYR A 150 CYS A 169 1 20 HELIX 10 10 ASP A 173 GLY A 207 1 35 HELIX 11 11 GLY A 207 PHE A 223 1 17 HELIX 12 12 GLU A 227 GLY A 248 1 22 HELIX 13 13 ASP A 249 ASN A 267 1 19 HELIX 14 14 GLN A 268 ILE A 271 5 4 HELIX 15 15 LEU A 275 GLU A 280 1 6 HELIX 16 16 PRO A 282 VAL A 293 1 12 HELIX 17 17 LEU A 305 VAL A 310 1 6 HELIX 18 18 ASP A 314 ALA A 322 1 9 HELIX 19 19 ALA A 322 ARG A 337 1 16 HELIX 20 20 SER A 342 CYS A 361 1 20 HELIX 21 21 ASP A 365 TYR A 370 1 6 HELIX 22 22 VAL A 373 VAL A 415 1 43 HELIX 23 23 SER A 419 CYS A 438 1 20 HELIX 24 24 PRO A 441 GLU A 465 1 25 HELIX 25 25 SER A 470 GLU A 479 1 10 HELIX 26 26 ASN A 483 LEU A 491 1 9 HELIX 27 27 SER A 517 LYS A 536 1 20 HELIX 28 28 GLU A 542 LYS A 560 1 19 HELIX 29 29 SER B 5 GLY B 15 1 11 HELIX 30 30 GLY B 15 LEU B 31 1 17 HELIX 31 31 PRO B 35 ASP B 56 1 22 HELIX 32 32 SER B 65 THR B 79 1 15 HELIX 33 33 MET B 87 ALA B 92 1 6 HELIX 34 34 PRO B 96 HIS B 105 1 10 HELIX 35 35 GLU B 119 ASN B 130 1 12 HELIX 36 36 ASN B 130 HIS B 146 1 17 HELIX 37 37 TYR B 150 CYS B 169 1 20 HELIX 38 38 LYS B 174 GLY B 207 1 34 HELIX 39 39 GLY B 207 PHE B 223 1 17 HELIX 40 40 GLU B 227 GLY B 248 1 22 HELIX 41 41 ASP B 249 ASN B 267 1 19 HELIX 42 42 GLN B 268 ILE B 271 5 4 HELIX 43 43 LYS B 274 GLU B 280 1 7 HELIX 44 44 PRO B 282 GLU B 292 1 11 HELIX 45 45 LEU B 305 VAL B 310 1 6 HELIX 46 46 ASP B 314 ALA B 322 1 9 HELIX 47 47 ALA B 322 ARG B 337 1 16 HELIX 48 48 SER B 342 CYS B 361 1 20 HELIX 49 49 ASP B 365 TYR B 370 1 6 HELIX 50 50 ALA B 371 ASP B 375 5 5 HELIX 51 51 GLU B 376 GLN B 397 1 22 HELIX 52 52 LEU B 398 VAL B 415 1 18 HELIX 53 53 SER B 419 CYS B 438 1 20 HELIX 54 54 PRO B 441 THR B 467 1 27 HELIX 55 55 SER B 470 GLU B 479 1 10 HELIX 56 56 ASN B 483 LEU B 491 1 9 HELIX 57 57 SER B 517 LYS B 536 1 20 HELIX 58 58 THR B 540 CYS B 558 1 19 SSBOND 1 CYS A 53 CYS A 62 1555 1555 2.03 SSBOND 2 CYS A 75 CYS A 91 1555 1555 2.02 SSBOND 3 CYS A 90 CYS A 101 1555 1555 2.03 SSBOND 4 CYS A 124 CYS A 169 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 177 1555 1555 2.03 SSBOND 6 CYS A 200 CYS A 246 1555 1555 2.04 SSBOND 7 CYS A 245 CYS A 253 1555 1555 2.04 SSBOND 8 CYS A 265 CYS A 279 1555 1555 2.03 SSBOND 9 CYS A 278 CYS A 289 1555 1555 2.03 SSBOND 10 CYS A 316 CYS A 361 1555 1555 2.02 SSBOND 11 CYS A 360 CYS A 369 1555 1555 2.03 SSBOND 12 CYS A 392 CYS A 438 1555 1555 2.03 SSBOND 13 CYS A 437 CYS A 448 1555 1555 2.05 SSBOND 14 CYS A 461 CYS A 477 1555 1555 2.02 SSBOND 15 CYS A 476 CYS A 487 1555 1555 2.04 SSBOND 16 CYS A 514 CYS A 559 1555 1555 2.01 SSBOND 17 CYS B 53 CYS B 62 1555 1555 2.03 SSBOND 18 CYS B 75 CYS B 91 1555 1555 2.03 SSBOND 19 CYS B 90 CYS B 101 1555 1555 2.03 SSBOND 20 CYS B 124 CYS B 169 1555 1555 2.03 SSBOND 21 CYS B 168 CYS B 177 1555 1555 2.03 SSBOND 22 CYS B 200 CYS B 246 1555 1555 2.02 SSBOND 23 CYS B 245 CYS B 253 1555 1555 2.04 SSBOND 24 CYS B 265 CYS B 279 1555 1555 2.03 SSBOND 25 CYS B 278 CYS B 289 1555 1555 2.03 SSBOND 26 CYS B 316 CYS B 361 1555 1555 2.03 SSBOND 27 CYS B 360 CYS B 369 1555 1555 2.04 SSBOND 28 CYS B 392 CYS B 438 1555 1555 2.04 SSBOND 29 CYS B 437 CYS B 448 1555 1555 2.04 SSBOND 30 CYS B 461 CYS B 477 1555 1555 2.02 SSBOND 31 CYS B 476 CYS B 487 1555 1555 2.03 SSBOND 32 CYS B 514 CYS B 559 1555 1555 2.03 CISPEP 1 GLU A 95 PRO A 96 0 -0.28 CISPEP 2 GLU B 95 PRO B 96 0 1.06 SITE 1 AC1 6 LEU A 387 ASN A 391 ARG A 410 TYR A 411 SITE 2 AC1 6 LEU A 430 SER A 489 SITE 1 AC2 9 TYR A 150 LYS A 199 TRP A 214 ARG A 218 SITE 2 AC2 9 ARG A 222 LEU A 238 HIS A 242 ARG A 257 SITE 3 AC2 9 ALA A 291 SITE 1 AC3 9 GLU B 16 LYS B 20 ASN B 391 LEU B 407 SITE 2 AC3 9 TYR B 411 LEU B 430 VAL B 433 LEU B 453 SITE 3 AC3 9 SER B 489 SITE 1 AC4 13 ASN B 99 GLU B 100 TYR B 150 LYS B 195 SITE 2 AC4 13 LYS B 199 TRP B 214 ARG B 218 ARG B 222 SITE 3 AC4 13 LEU B 238 HIS B 242 HIS B 247 ARG B 257 SITE 4 AC4 13 ALA B 291 CRYST1 54.710 55.200 119.880 81.27 91.09 65.29 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018278 -0.008411 0.001856 0.00000 SCALE2 0.000000 0.019942 -0.003563 0.00000 SCALE3 0.000000 0.000000 0.008475 0.00000 MTRIX1 1 0.427600 0.903300 0.034600 -48.01580 1 MTRIX2 1 0.903600 -0.428200 0.012000 -33.36710 1 MTRIX3 1 0.025700 0.026100 -0.999300 57.40810 1